CA 19-9 - Predilute - 6.0 ml

Product Description

CA 19-9 antibody, a carbohydrate antigenic determinant identified as a sialylated lacto-N-fucopentose II, is related to the Lewis blood group. CA 19-9 might play a role in the process of tumour progression as an adhesion molecule. The CA 19-9 antibody has been shown to label adenocarcinomas of the pancreas, stomach, breast, colon, and gall bladder. CA 19-9 is also expressed in primary and metastatic ovarian carcinomas. Studies show that CA 19-9 positive expression may be a predictor of increased cancer mortality.

Specifications:

• Intended Use: IVD
• Species Reactivity: Human
• Source: Mouse Monoclonal
• Clone: 121SLE
• Isotype: IgM
• Antigen: CA19-9
• Localization: Cytoplasmic
• Positive Control: Ovarian or colon carcinomas